Marchex (NASDAQ:MCHX) Announces Earnings Results, Misses Expectations By $0.02 EPS

Marchex (NASDAQ:MCHX) posted its quarterly earnings results on Wednesday. The technology company reported ($0.03) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.02), FiscalAI reports. The company had revenue of $10.62 million for the quarter, compared to analysts’ expectations of $10.89 million. Marchex had a negative return on equity of 14.32% and a negative net margin of 11.15%.

Here are the key takeaways from Marchex’s conference call:

• Marchex said it believes it is at a positive inflection point, with better execution, rising penetration in its customer base, and early signs that its AI strategy is creating sales momentum.
• The company reported Q1 2026 revenue of $10.6 million, with new sales and upsells partly offset by migration-related revenue pressure from moving legacy platforms to Marchex Engage.
• Management raised near-term expectations, guiding Q2 adjusted EBITDA to $1.6 million-$1.8 million and saying Q3 could reach about $2 million or more on a standalone basis, or $2.5 million or more if the Archenia deal closes.
• Marchex and Archenia are already jointly selling early AI-based products, and management said nearly half of the top customers pitched have already bought one or more offerings on a recurring or pilot basis.
• The company expects the pending Archenia acquisition to close in July 2026, pending stockholder approval, and says the combination could expand its addressable market, lift margins, and support a longer-term revenue run rate of about $60 million annually.

Marchex Stock Performance

Shares of NASDAQ MCHX traded up $0.02 during midday trading on Thursday, hitting $1.62. The company’s stock had a trading volume of 21,337 shares, compared to its average volume of 15,933. Marchex has a 1-year low of $1.32 and a 1-year high of $2.31. The firm’s fifty day moving average price is $1.56 and its 200-day moving average price is $1.61. The firm has a market cap of $71.13 million, a P/E ratio of -14.73 and a beta of 1.95.

Wall Street Analyst Weigh In

A number of equities analysts have recently commented on MCHX shares. Weiss Ratings reissued a “sell (d-)” rating on shares of Marchex in a research note on Tuesday, April 21st. Zacks Research raised shares of Marchex from a “strong sell” rating to a “hold” rating in a research note on Thursday, February 12th. One research analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, Marchex currently has a consensus rating of “Reduce”.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in MCHX. Kanen Wealth Management LLC acquired a new stake in shares of Marchex in the first quarter valued at approximately $813,000. Jane Street Group LLC acquired a new stake in shares of Marchex in the first quarter valued at approximately $30,000. Manatuck Hill Partners LLC acquired a new stake in shares of Marchex in the second quarter valued at approximately $88,000. Finally, XTX Topco Ltd acquired a new stake in shares of Marchex in the fourth quarter valued at approximately $26,000. 73.46% of the stock is currently owned by institutional investors.

Marchex Company Profile

Marchex, Inc (NASDAQ: MCHX) operates a call data and analytics platform designed to help businesses measure and optimize customer interactions. The company’s core services include call tracking, conversational analytics and performance marketing solutions that attribute phone calls to specific advertising campaigns. By capturing and analyzing voice interactions, Marchex enables advertisers, agencies and brands to gain actionable insights into caller intent, marketing ROI and customer behavior.

Through its suite of technologies, Marchex offers real-time call monitoring, keyword spotting and AI-driven transcription to surface trends and conversion signals from inbound calls.